A fair process should be the base expectation of any person or organisation engaging with the government, even global biopharmaceutical companies, not least when they are paying for it.
Latest Video
New Stories
-
GSK out to an early lead in Rare Cancers Australia Kosi Challenge 'Pharma Cup'
February 7, 2025 - - Latest News -
'In an optimal, equitable system, access to evidence-based, cost-effective genomics-guided medicines would be provided to all'
February 7, 2025 - - Latest News -
The 'Dispatched' week in review podcast - 7 February
February 6, 2025 - - Podcast -
Sanofi Ventures joins investors backing Australian radionuclide company
February 6, 2025 - - Australian Biotech -
'One believes things because one has been conditioned to believe them'
February 6, 2025 - - Latest News -
RFK Jr on the cusp of securing his nomination to lead the US health department
February 6, 2025 - - Latest News -
Omico calls for major government-industry support of fundamental change in cancer treatment
February 5, 2025 - - Latest News